Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Biogen Inc (BIIB.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-30211.03269.00Buy
2022-04-26206.99244.00Buy
2022-07-19220.26247.00Buy
2022-07-20207.49238.00Buy
2022-10-05261.69309.00Buy
2022-10-25273.56319.00Buy
2022-11-30305.17338.00Buy
2023-01-29290.08337.00Buy
2023-02-15278.98340.00Buy
2023-04-20290.27347.00Buy
2023-04-26288.04346.00Buy
2023-07-24277.00335.00Buy
2023-07-26265.25328.00Buy
2023-11-01239.62312.00Buy
2023-11-10224.79311.00Buy
2024-01-24247.16276.00Neutral
2024-02-15223.35250.00Neutral
2024-04-17192.16214.00Neutral
2024-04-26208.90217.00Neutral
2024-07-17228.33234.00Neutral
2024-10-03184.78202.00Neutral
2024-11-01173.79184.00Neutral
2025-02-06142.37163.00Neutral
2025-02-27139.88157.00Neutral
2025-04-10113.38134.00Neutral
2025-05-05121.80119.00Neutral

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 25% above the MRA for a Buy rating, and at -25% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.